Royalty Pharma: welcome clarity mixed with unwelcome ambiguity

At the end of April the Court of Justice of the European Union (CJEU) delivered its judgment in Case C-650/17 Royalty Pharma Collection Trust.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

UKIPO cancels SPC extension at owner’s request

16 June 2020 The UK Intellectual Property Office has agreed to revoke an extension to a supplementary protection certificate for immunosuppressant tocilizumab, at the request of the owners.

Europe

Unitary SPC should follow new patent system: EC official

11 June 2020 The European Commission wants to implement a unitary supplementary protection certificate, its top IP official has said.

Americas

Will the EU’s SPC manufacturing waiver weaken European pharma’s IP?

20 May 2020 Despite dire warnings by the US Chamber of Commerce, the impact of the EU’s SPC waiver won’t be known for years, says Paul Williams of Lewis Silkin.

More on this story

Big Pharma

UKIPO cancels SPC extension at owner’s request

16 June 2020 The UK Intellectual Property Office has agreed to revoke an extension to a supplementary protection certificate for immunosuppressant tocilizumab, at the request of the owners.

Europe

Unitary SPC should follow new patent system: EC official

11 June 2020 The European Commission wants to implement a unitary supplementary protection certificate, its top IP official has said.

Americas

Will the EU’s SPC manufacturing waiver weaken European pharma’s IP?

20 May 2020 Despite dire warnings by the US Chamber of Commerce, the impact of the EU’s SPC waiver won’t be known for years, says Paul Williams of Lewis Silkin.

More on this story

Big Pharma

UKIPO cancels SPC extension at owner’s request

16 June 2020 The UK Intellectual Property Office has agreed to revoke an extension to a supplementary protection certificate for immunosuppressant tocilizumab, at the request of the owners.

Europe

Unitary SPC should follow new patent system: EC official

11 June 2020 The European Commission wants to implement a unitary supplementary protection certificate, its top IP official has said.

Americas

Will the EU’s SPC manufacturing waiver weaken European pharma’s IP?

20 May 2020 Despite dire warnings by the US Chamber of Commerce, the impact of the EU’s SPC waiver won’t be known for years, says Paul Williams of Lewis Silkin.

More features

Life sciences leaders recognised at LSPN Awards USA 2025

LSPN: Counsel grapple with AI’s impact on training and critical thinking

LSPN: Trump's policy storm causing chaos and confusion

Taylor Wessing expands in Europe with Paris team

LSPN: Using ‘the patentee’s friend’ in Section 112 claims

Novartis settles with licensee of blood cancer therapy day before trial

US warns of rising counterfeit drug threat from India and China

Judge denies Pfizer and BioNTech bid to see off COVID-19 vaccine suit

Royalty Pharma: welcome clarity mixed with unwelcome ambiguity

More on this story

Editor's picks

Editor's picks

More on this story

More on this story

More features